Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac vs Ketorolac vs Diclofenac for Acute Pseudophakic CME
NCT00595543Phase 4Completed
- Sponsor
- BP Consulting
- Start
- Jan 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bromfenac sodium, ketorolac and diclofenac in pseudophakic cystoid macular edema (PCME), sponsored by BP Consulting. Started Jan 2008; status: completed.
02
Drugs
bromfenac sodiumketorolacdiclofenac
03
Conditions
pseudophakic cystoid macular edema (PCME)
Beyond the preview
Go deeper on NCT00595543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00595543.